 |
| October
6, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Joseph Truitt, MBA, CEO & Board
Director, iECURE Inc. |
| In
this Q&A, Truitt discusses the UPenn
gene therapy data that led him to join
iECURE, the company's platform strategy of
using the PCSK9 locus as a genomic
"landing pad" for multiple pediatric liver
diseases, and early clinical evidence that
has shaped development of its lead
candidate. More |
|
|
- Beaconcure: Launches Verify Intelligence,
Now in Production at a Top 10
Biopharmaceutical Company More
- Charles River and Autolomous: Partner to
Transform Laboratory Execution Systems More
- Collegium: Launches "Start Talking ADHD"
With Practical Support to Help Families
Navigate Care, School and Everyday Life More
- Electron Bio: Launches FAST GMP Modular
Cleanroom Platform and FAST QMS More
- Forward Therapeutics: Positive Phase 1 Data
for Potential Best-in-Class Oral TNFR1
Signaling Inhibitor FT2109, Supporting
Advancement Into Phase 2 Development More
- Korro: First Cohort Dosed in Phase 1/2
Clinical Trial (ANCHOR) for KRRO-121 More
- MapLight Therapeutics: Celebrates Co-Founder
Dr. Karl Deisseroth on Receipt of 2026 Nobel
Prize in Physiology or Medicine for the
Development of Optogenetics More
- Pillar Biosciences: Launches oncoReveal
Myeloid v2 Panel, Expanding to 80 Genes and
Advancing Detection of Long and Multiple
FLT3-ITDs
More
- Prime Medicine: First Patient Dosed in
Global Phase 1/2 Clinical Trial of PM577a for
H1069Q-Mutated Wilson Disease More
- Privo Technologies: Clinical Update From the
Ongoing Phase 2 Trial of PRV111, the First
Non-Surgical Therapy in Development for
Early-Stage Oral Cancer More
- Sironax: Named to Fierce Biotech’s “Fierce
15” List of the Most Innovative and Promising
Private Biotechs of 2026 More
- Trinity: Next Gen Launch Report Shows
Pharmaceutical Launches Deliver Strong
Performance in the Face of Uncertainty More
- Zag Bio: Advances ZAG-101 into Clinical
Development for Type 1 Diabetes More
|
|
 |
 |
CRCFO
Advisory
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
- Arboretum: Launches to Redefine Precision
Medicine for Common Diseases as a
Next-Generation Molecular Information
Company More
- Bicara Therapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Global Healthcare and Life Sciences R&D
Partnerships – Q3 2026 Review More
- Repligen: Completes Acquisition of BioLife
Solutions More
- Spyre Therapeutics: Pricing of $350.0
Million Public Offering of Common Stock More
- Standard BioTools: Agreement to Sell
Microfluidics Business to ARCHIMED More
- Verastem Oncology: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Vor Bio: Inducement Grant Under Nasdaq
Listing Rule 5635(c)(4) More
|
|
 |
| The
future of advanced therapies:
Explore challenges and
opportunities shaping patient
access, site-of-care expansion and
commercialization. |
| Access the
Report → |
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Arbor Biotechnologies Sets Out CNS Gene
Editing Push With Three ALS Candidates at
Meeting on the Mesa More
- Big4Bio CEO Weekly Q&A: Joseph
Truitt, MBA, CEO & Board Director,
iECURE Inc. More
- Biotech & Pharma Updates | October 5,
2026 More
- Flicking the Switch: Five Scientists Honored
at 2026 Warren Alpert Foundation Symposium for
Hemoglobinopathy Research More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ‘We’re Here at the Party Now:’
Astrazeneca Opens New Kendall Hub With Big
Hiring Plans More*
More
More
|
|
 |
 |
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- Aphios: Appoints Dr. Juliette M. Tuakli to
Board of Directors More
- Avilar Therapeutics: Names Leslie
Meltzer, Ph.D. as Chief Executive Officer More
- Cerevance: Appoints Karl Kieburtz, M.D.,
M.P.H., as Chief Medical Officer More
- Oak Hill Bio: Appoints Joerg Hipp, PhD as
Chief Translational Science Officer More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- OPPORTUNITY: Director of Compliance, Remote
More
- Slone Partners: Beyond the Org Chart
- Redefining Leadership Roles After an
Acquisition More
- Slone Partners: Places
Warren Cresswell as Chief Executive Officer at
Perspectum More
- 2 Massachusetts Biotechs Call It Quits More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Biocom’s San Diego Life Science CEO
Summit Oct
8
- MassBioEd’s 25th Anniversary Gala Oct
21
- Biocom’s Bay Area CEO Summit Oct
23
- Biocom’s Greater LA CEO Summit Oct
27
- BioFuture Oct
27-28
- PODD: Partnership Opportunities in
Drug Delivery Oct
29-30
- Aggression in Mice: Bridging Evidence,
Best Practices, and Scientific Rigor Nov
4
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
